Evidence map›Paper›PMID 30967486›Full record

ArticleMolecular & cellular proteomics : MCP2019

TMT Labeling for the Masses: A Robust and Cost-efficient, In-solution Labeling Approach.

Jana Zecha, Shankha Satpathy, Tamara Kanashova, Shayan C Avanessian, M Harry Kane, Karl R Clauser, Philipp Mertins, Steven A Carr, Bernhard Kuster

Abstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 238 papers.

0numbers the graph read from it
0cells of the map it votes in
238citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

238 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Mass spectrometry proteomics for studying mitostasis.Protein science : a publication of the Protein Society · 2026
    Review
  9. Article
  10. ESCRT-0 regulates AMPA receptor currents and CabioRxiv : the preprint server for biology · 2026
    Article
  11. PrPStem cell reports · 2026
    Article
  12. Beta-Adrenergic Stimulation andbioRxiv : the preprint server for biology · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Chromatin association promotes UBR5-mediated degradation of Rb.bioRxiv : the preprint server for biology · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

178 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jana ZechaFrom the ‡Chair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Germany.
Shankha Satpathy§Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.
Tamara Kanashova¶Max Delbrück Center for Molecular Medicine in the Helmholtz Society, Berlin, Germany.
Shayan C Avanessian§Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.
M Harry Kane§Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.
Karl R Clauser§Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.
Philipp Mertins§Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA;; ¶Max Delbrück Center for Molecular Medicine in the Helmholtz Society, Berlin, Germany;; ‖Berlin Institute of Health, Berlin, Germany.
Steven A Carr§Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA;. Electronic address: scarr@broad.mit.edu.
Bernhard KusterFrom the ‡Chair of Proteomics and Bioanalytics, Technical University of Munich (TUM), Freising, Germany;; **Bavarian Biomolecular Mass Spectrometry Center (BayBioMS), TUM, Freising, Germany. Electronic address: kuster@tum.de.

Funding

A Biochemical Roadmap of Exercise Signaling - Pilot Project for MoTrPAC ConsortiumU24DK112340 · NIDDK · BROAD INSTITUTE, INC. · PI STEVEN A CARR, Clary B Clish · 2017 to 2026
$16.2M
MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALSU01CA214125 · NCI · BAYLOR COLLEGE OF MEDICINE · PI ANURAG, MEENAKSHI, CARR, STEVEN A · 2017 to 2021
$7.0M
Center of Excellence for High Throughput Proteogenomic CharacterizationU24CA210986 · NCI · BROAD INSTITUTE, INC. · PI CARR, STEVEN A, GILLETTE, MICHAEL A · 2016 to 2020
$6.4M
NCI NIH HHS U01 CA214125NCI NIH HHS U24 CA210986NIDDK NIH HHS U24 DK112340
6 · The paper itself

Abstract

Isobaric stable isotope labeling using, for example, tandem mass tags (TMTs) is increasingly being applied for large-scale proteomic studies. Experiments focusing on proteoform analysis in drug time course or perturbation studies or in large patient cohorts greatly benefit from the reproducible quantification of single peptides across samples. However, such studies often require labeling of hundreds of micrograms of peptides such that the cost for labeling reagents represents a major contribution to the overall cost of an experiment. Here, we describe and evaluate a robust and cost-effective protocol for TMT labeling that reduces the quantity of required labeling reagent by a factor of eight and achieves complete labeling. Under- and overlabeling of peptides derived from complex digests of tissues and cell lines were systematically evaluated using peptide quantities of between 12.5 and 800 μg and TMT-to-peptide ratios (wt/wt) ranging from 8:1 to 1:2 at different TMT and peptide concentrations. When reaction volumes were reduced to maintain TMT and peptide concentrations of at least 10 mm and 2 g/l, respectively, TMT-to-peptide ratios as low as 1:1 (wt/wt) resulted in labeling efficiencies of > 99% and excellent intra- and interlaboratory reproducibility. The utility of the optimized protocol was further demonstrated in a deep-scale proteome and phosphoproteome analysis of patient-derived xenograft tumor tissue benchmarked against the labeling procedure recommended by the TMT vendor. Finally, we discuss the impact of labeling reaction parameters for N-hydroxysuccinimide ester-based chemistry and provide guidance on adopting efficient labeling protocols for different peptide quantities.

Indexed as

Cost-Benefit AnalysisMass SpectrometryHeLa CellsHumansIsotope LabelingJurkat CellsPeptidesProteomeProteomicsReference StandardsReproducibility of ResultsPeptidesProteomeLabeling EfficiencyNHS Ester ChemistryPeptides*PhosphoproteomePost-Translational Modifications*QuantificationStable Isotope LabelingTandem Mass SpectrometryTandem Mass Tags

Identifiers

PMID30967486
PMCPMC6601210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.